Generics

Filter

Current filters:

None

Popular Filters

1176 to 1200 of 1237 results

Navamedic on track to launch eight generics; sales rise 43%

27-08-2011

Norwegian drugmaker Navamedic ASA (OSE: NAVA) says sales in the second quarter of 2011 were record high…

FinancialGenericsMarkets & MarketingNavamedic

Google in $500 million settlement with DoJ over unlicensed drug ads

26-08-2011

On-line search engine Google Inc has agreed to forfeit $500 million for allowing on-line Canadian pharmacies…

GenericsLegalMarkets & MarketingNorth AmericaPharmaceutical

Jordan’s Hikma delivers 10.4% sales growth in first half 2011

25-08-2011

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) has reported interim results for the six months…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Par Pharma to acquire niche generics producer Anchen for $410 million

25-08-2011

Par Pharmaceutical (NYSE: PRX) has entered into a definitive agreement to acquire fellow USA-based Anchen…

Anchen PharmaceuticalsGenericsMergers & AcquisitionsPar Pharmaceuticals

Spain hopes to save 2.4 billion euros by ordering doctors to Rx generics

25-08-2011

As part of moves to reduce the nation’s budget deficit, Spain’s socialist government has passed…

EuropeFinancialGenericsLegalPharmaceuticalRegulation

UAE pharmaceutical industry set to benefit from lifestyle changes

24-08-2011

A recent Dubai Chamber of Commerce and Industry study indicates that the United Arab Emirates (UAE) pharmaceutical…

GenericsHealthcareMarkets & MarketingPharmaceuticalRest of the World

Changing the mood of Brazilian antidepressant market; fake Levitra

24-08-2011

The Vice President of Brazil’s Superior Court of Justice (STJ), Minister Felix Fischer, has restored…

BayerGenericsLevitraLexaproLundbeckNeurologicalPharmaceuticalRegulationReproductiveSouth America

IMS debuts MIDAS Biosimilars, a new market tool for fast-developing pharma segment

22-08-2011

IMS Health has launched IMS MIDAS Biosimilars, a market measurement tool that enables clients to assess…

BiotechnologyGenericsGlobalMarkets & Marketing

Australia’s generics firms also welcome Senate report on government administration of the PBS

21-08-2011

Following the release of the Australia’s Senate Finance and Administration References Committee…

Asia-PacificGenericsHealthcarePharmaceuticalPoliticsRegulation

Intellipharmaceutics and Par Pharma expand Focalin accord

19-08-2011

Canada’s Intellipharmaceutics International (TSX:I) and US generic drugmaker Par Pharmaceuticals…

Focalin XRGenericsIntellipharmaceuticsLicensingNeurologicalPar Pharmaceuticals

Call for IP protection norms for manufacturing generic drugs in India

18-08-2011

India’s Department of Commerce has called for coordination among various ministries for a consensus…

Asia-PacificGenericsPatents

Endo Pharma sues Mylan over Frova patent infringement

17-08-2011

US generic drugmaker Mylan (Nasdaq: MYL) yesterday confirmed that the company and its subsidiary Mylan…

Endo PharmaceuticalsFrovaFrovatriptan SuccinateGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaRegulation

Drug shortages in USA leading to price gouging, possible safety issues

17-08-2011

As health care providers in the USA deal with record rates of drug shortages, some “gray market"…

GenericsHealthcareMarkets & MarketingNorth AmericaPharmaceuticalPricing

Pfizer wins case to stop Teva selling generic Viagra in USA

16-08-2011

Global pharmaceutical behemoth Pfizer (NYSE: PFE) revealed yesterday that it has prevailed in its patent…

GenericsLegalNorth AmericaPatentsPfizerPharmaceuticalReproductiveTeva Pharmaceutical IndustriesViagra

Pharma contract manufacturing revenues to reach $64.07 billion in 2016, says Visiongain

15-08-2011

The global contract manufacturing sector will generate revenues of $64.07 billion in 2016, according…

GenericsGlobalMarkets & MarketingPharmaceutical

South Korea to cut pharma prices by average 17% to save $1.94 billion

15-08-2011

In a move that is likely to curb current growth prospects for the pharmaceutical industry in South Korea,…

Asia-PacificGenericsPharmaceuticalPricing

Good first-half results from Stada Arz driven by branded and generic drugs

11-08-2011

German drugmaker Stada Arzneimittel reported first-half 2011 results with 7% growth in group sales to…

FinancialGenericsPharmaceuticalSTADA Arzneimittel

Tentative OK from US FDA for Watson's rosuvastatin zinc tablets

10-08-2011

US drugmaker Watson Pharmaceuticals (NYSE: WPI) says that its subsidiary, Watson Laboratories, has received…

AstraZenecaCardio-vascularCrestorGenericsNorth AmericaRegulationrosuvastatinWatson Pharmaceuticals

Generic penetration of Japanese pharma likely to fall short of 2012 government target

09-08-2011

Innovation is the sole driver for Japanese pharma in the short-term, according to Global Biopharma Outlook…

Asia-PacificGenericsMarkets & MarketingPharmaceutical

US payers will want more info on biosimilars than FDA may accept for approval, survey finds

08-08-2011

To feel comfortable with biosimilars, US payers survey by advisory firm Decision Resources indicate they…

BiotechnologyGenericsNorth AmericaRegulationResearch

Ranbaxy posts 2nd-qtr 2011 net profit down 25%

07-08-2011

India’s largest drugmaker Ranbaxy (RANB: BO) reported second-quarter 2011 financial results, with…

Daiichi SankyoFinancialGenericsRanbaxy Laboratories

1176 to 1200 of 1237 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top